ZZU Prof. Zhang Zhenzhong’s Group Makes Positive Progress in Ca2+ Tumor Sensitization Treatment Research
Publisher: Yang Ming   From: zzu   Publish Date: 2018.09.26   Read Count: 45
Recently, Zhang Zhenzhong’s Group, a team of Pharmacy School of ZZU, has made positive progress in the field of Ca2+ Tumor Sensitization Treatment. The research results were published in a paper entitled “Enhanced Intracellular Ca2+ Nanogen for Tumor-Specific Synergistic Therapy via Disruption of Mitochondrial Ca2+ Homeostasis and Photothermal Therapy”, in the internationally renowned journal ″ACS Nano, 2018, 12, 6806-6818″. PhD candidate Xu Lihua and master student Tong Guihua tied as first authors, Associate Professor Shi Jinjin and Prof. Zhang Zhenzhong were co-authors, with ZZU as the only completion unit. (translator Song Gencheng)郑州大学版权所有,禁止非法转载!2018-10-24 12:31:51
Compatible for Internet Explorer 8+Firefox 18+Safari 5+Chrome 22+Opera 12+ etc. Browser